PDS Biotechnology (PDSB)
(Delayed Data from NSDQ)
$3.10 USD
+0.09 (2.99%)
Updated Sep 11, 2024 04:00 PM ET
After-Market: $3.12 +0.02 (0.65%) 4:46 PM ET
2-Buy of 5 2
D Value B Growth B Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/12/24 |
---|---|
Current Quarter | -0.31 |
EPS Last Quarter | -0.23 |
Last EPS Surprise | 25.81% |
ABR | 1.00 |
Earnings ESP
|
10.64% |
---|---|
Current Year | -1.30 |
Next Year | -1.42 |
EPS (TTM) | -1.22 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 1.10M |
# of Estimates | NA | NA | NA | 1 |
High Estimate | NA | NA | NA | 1.10M |
Low Estimate | NA | NA | NA | 1.10M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.31 | -0.36 | -1.30 | -1.42 |
# of Estimates | 3 | 3 | 4 | 3 |
Most Recent Consensus | -0.28 | -0.34 | -1.28 | -1.54 |
High Estimate | -0.28 | -0.34 | -1.17 | -1.23 |
Low Estimate | -0.33 | -0.39 | -1.38 | -1.54 |
Year ago EPS | -0.35 | -0.34 | -1.39 | -1.30 |
Year over Year Growth Est. | 11.43% | -5.88% | 6.47% | -9.17% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 0 |
Up Last 60 Days | 1 | 1 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.31 | -0.36 | -1.30 | -1.42 |
7 Days Ago | -0.31 | -0.36 | -1.30 | -1.42 |
30 Days Ago | -0.33 | -0.37 | -1.31 | -1.36 |
60 Days Ago | -0.37 | -0.40 | -1.46 | -1.60 |
90 Days Ago | -0.37 | -0.40 | -1.46 | -1.60 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.28 | -0.34 | -1.28 | -1.54 |
Zacks Consensus Estimate | -0.31 | -0.36 | -1.30 | -1.42 |
Earnings ESP | 10.64% | 4.67% | 1.73% | -8.70% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.23 | -0.30 | -0.34 | -0.35 | NA |
Estimate | -0.31 | -0.37 | -0.39 | -0.42 | NA |
Difference | 0.08 | 0.07 | 0.05 | 0.07 | 0.07 |
Surprise | 25.81% | 18.92% | 12.82% | 16.67% | 18.56% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more